The National Cancer Institute is offering grants for exploratory research projects to advance and validate technologies enhancing the quality of biospecimens used in cancer research. This opportunity focuses on addressing degradation issues in the collection, processing, and storage of cancer-relevant samples. Projects must demonstrate a novel capability in maximizing sample quality for downstream analyses, with the potential to accelerate cancer biology, early detection, treatment, and more. Applications should not focus on established technologies but rather on emerging methods. Deadline for submission is Sep 26, 2016.
Opportunity ID: 280444
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-16-004 |
| Funding Opportunity Title: | Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science (R33) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 09, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 26, 2016 |
| Current Closing Date for Applications: | Sep 26, 2016 |
| Archive Date: | Oct 27, 2016 |
| Estimated Total Program Funding: | $800,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Private institutions of higher education Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) State governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the advanced development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care. This includes technologies that address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens. This FOA solicits R33 applications where proof-of-principle for the emerging technology or methodology has been provided with supportive preliminary data demonstrating a novel capability for maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or cancer health disparities. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this FOA and will not be reviewed. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-16-004.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | FORMS-C | PKG00220036 | Jan 26, 2016 | Mar 23, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00221844 | Apr 26, 2016 | Sep 26, 2016 | View |
Package 1
Mandatory forms
280444 RR_SF424_2_0-2.0.pdf
280444 PHS398_ResearchPlan_2_0-2.0.pdf
280444 PHS398_CoverPageSupplement_2_0-2.0.pdf
280444 RR_Budget_1_3-1.3.pdf
280444 RR_KeyPersonExpanded_2_0-2.0.pdf
280444 RR_OtherProjectInfo_1_3-1.3.pdf
280444 PerformanceSite_2_0-2.0.pdf
Optional forms
280444 PlannedReport-1.0.pdf
280444 PHS398_CumulativeInclusionReport-1.0.pdf
280444 RR_SubawardBudget30_1_3-1.3.pdf
Package 2
Mandatory forms
280444 RR_SF424_2_0-2.0.pdf
280444 PHS398_CoverPageSupplement_3_0-3.0.pdf
280444 RR_OtherProjectInfo_1_3-1.3.pdf
280444 PerformanceSite_2_0-2.0.pdf
280444 RR_KeyPersonExpanded_2_0-2.0.pdf
280444 RR_Budget_1_3-1.3.pdf
280444 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
280444 RR_SubawardBudget30_1_3-1.3.pdf
280444 PHS_Inclusion_Enrollment_Report-1.0.pdf
280444 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
